Nanohybrids for Enhanced Drug Delivery

3,295
Total downloads
15k
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 13 Nov 2018

Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway

Donglai Chen
Fuquan Zhang
Jinhui Wang
Hua He
Shanzhou Duan
Rongying Zhu
Chang Chen
Lichen Yin
Yongbing Chen

Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway

doi 10.3389/fphar.2018.01214

4,161 views
40 citations

ORIGINAL RESEARCH

Published on 21 Sep 2018

Evaluation of Chitosan Derivative Microparticles Encapsulating Superparamagnetic Iron Oxide and Doxorubicin as a pH-Sensitive Delivery Carrier in Hepatic Carcinoma Treatment: An in vitro Comparison Study

Meng-Yi Bai
Sung-Ling Tang
Meng-Han Chuang
Ting-Ying Wang
Po-da Hong

Evaluation of Chitosan Derivative Microparticles Encapsulating Superparamagnetic Iron Oxide and Doxorubicin as a pH-Sensitive Delivery Carrier in Hepatic Carcinoma Treatment: An in vitro Comparison Study

doi 10.3389/fphar.2018.01025

2,512 views
17 citations

ORIGINAL RESEARCH

Published on 09 Jul 2018

Layered Double Hydroxide Nanomaterials Encapsulating Angelica gigas Nakai Extract for Potential Anticancer Nanomedicine

Hyoung-Jun Kim
Gyeong Jin Lee
Ae-Jin Choi
Tae-Hyun Kim
Tae-il Kim
Jae-Min Oh

Layered Double Hydroxide Nanomaterials Encapsulating Angelica gigas Nakai Extract for Potential Anticancer Nanomedicine

doi 10.3389/fphar.2018.00723

5,840 views
29 citations

Share on

Frontiers in Pharmacology

Frontiers in Pharmacology

Pharmacology of Anti-Cancer Drugs

Participating Journals

Frontiers in Oncology
- Pharmacology of Anti-Cancer Drugs
- 3.5 impact factor
- 6.2 citescore

Impact

15kTopic views
10kArticle views
3,295Article downloads